R3 Stem Cell Mexico Introduces the IntelliCell for Improved Patient Outcomes

24 Aug R3 Stem Cell Mexico Introduces the IntelliCell for Improved Patient Outcomes

Posted at 07:50h in Blog, R3 Stem Cell International, Regenerative Medicine, stem cell therapy by siteadmin 0 Comments

0 Likes

R3 Stem Cell, the worldwide leader in regenerative procedures, has introduced its newest cutting-edge advancement in stem cell technology after years of research and development. The IntelliCell is now being incorporated into patient treatments at all of R3 Stem Cell Mexico‘s Centers of Excellence, with patients raving about the exceptional outcomes being experienced.

“We’ve always offered world-class stem cell therapy at our Mexico clinics, but now our R&D has placed us into the world’s elite with the IntelliCell.”

— CEO David Greene, MD, Ph.D., MBA

Quite simply, the IntelliCell is an incredibly pure, active, and potent mesenchymal stem cell. Production of IntelliCell has maintained unparalleled quality assurance standards for safety while providing effectiveness for patients that is first-rate. The “intelligent” cell is evaluated for safety, viability, activity, and differentiation potential. Should a cell fall short of the necessary parameters, it is not used.

According to R3 CEO David Greene, MD, Ph.D., MBA, “We’ve always offered world-class stem cell therapy at our Mexico clinics, but now our R&D has placed us into the world’s elite with the IntelliCell. We did all of this and kept our cell counts incredibly high while keeping our pricing extremely low. It’s all about first-rate patient outcomes!”

R3 Stem Cell’s process for offering the best stem cell treatment in Mexico begins with a free phone consultation. The R3 doctors will evaluate medical records and discuss with the person whether or not regenerative therapy is indicated.

Stem cell counts are important for therapy. R3 offers 30 million stem cells for just $2950, while 50 million stem cells are only $3950. All patients receiving 50 million or more cells also receive exosome therapy, which are stem cell byproducts that improve the outcomes.

“Along with the IntelliCell stem cell treatment, we found that exosomes dramatically improve patient outcomes. Our procedure volume has allowed us to offer those biologics free to patients!” added Dr. Greene.

With over 17,000 stem cell procedures having been performed in the last decade, R3 Stem Cell is the global leader in regenerative therapies.

The IntelliCell creation has continued the company’s tradition of keeping its place at the forefront of cost-effective, clinically superior treatments.

David Greene, MD, MBA

R3 Stem Cell International

+1 (888) 988-0515

Visit us on social media:

Source: https://www.einpresswire.com/article/549501040/r3-stem-cell-mexico-introduces-the-intellicell-for-improved-patient-outcomes?r=pa7h0aODc1XyGYI9tm

ABOUT US

The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.